Burden of hospital admissions caused by respiratory syncytial virus (RSV) in infants in England: A data linkage modelling study
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical)
Reference25 articles.
1. The burden of respiratory syncytial virus infection in young children;Hall;N Engl J Med,2009
2. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010
3. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017
4. Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007-2012;Reeves;Influenza Other Respi Viruses,2017
5. Epidemiology of laboratory-confirmed respiratory syncytial virus infection in young children in England, 2010–2014: the importance of birth month;Reeves;Epidemiol Infect,2016
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Modelling the potential clinical and economic impact of universal immunisation with nirsevimab versus standard of practice for protecting all neonates and infants in their first respiratory syncytial virus season in Spain;BMC Infectious Diseases;2024-09-06
2. Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes;Infectious Diseases and Therapy;2024-09-05
3. Respiratory Syncytial Virus Hospital Admission Rates and Patients’ Characteristics Before the Age of 2 Years in England, 2015–2019;Pediatric Infectious Disease Journal;2024-07-05
4. RSV in Young Children During and After the COVID-19 Pandemic—Implications for Delaying the Age of First Infection;Pediatric Infectious Disease Journal;2024-06-26
5. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol;Human Vaccines & Immunotherapeutics;2024-05-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3